Global Recombinant Trypsin Solution Market Insights, Forecast to 2025

Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
According to the form, the classification of recombinant trypsin solution includes solid type, liquid type. And the proportion of liquid type in 2017 is about 65.53%.
Recombinant trypsin solution is widely used for insulin manufacturing, vaccines manufacturing and cell culture. The most proportion of recombinant trypsin solution is used for cell culture, and the proportion in 2017 is about 39%.
Europe region is the largest supplier of recombinant trypsin solution, with a production market share nearly 66% in 2017. North America is the second largest supplier of recombinant trypsin solution, enjoying production market share nearly 27% in 2017.
North American is the largest consumption place, with a consumption market share nearly 42% in 2017. Following North American, North American is the second largest consumption place with the consumption market share of 33%.
The global Recombinant Trypsin Solution market is valued at 37 million US$ in 2018 and will reach 59 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Trypsin Solution market based on company, product type, end user and key regions.

This report studies the global market size of Recombinant Trypsin Solution in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Trypsin Solution in these regions.
This research report categorizes the global Recombinant Trypsin Solution market by top players/brands, region, type and end user. This report also studies the global Recombinant Trypsin Solution market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novozymes
Thermo Fisher
Roche
BBI Group
Merck
Biological Industries
Yaxin Bio
Lonza
Yocon Hengye Bio
Biosera
BasalMedia
Solarbio

Market size by Product
Solid
Liquid
Market size by End User
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Recombinant Trypsin Solution market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Recombinant Trypsin Solution market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Recombinant Trypsin Solution companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Recombinant Trypsin Solution submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Trypsin Solution are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K L). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Trypsin Solution market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.